Summary Lower birth weight has a negative association with adult BMC and body composition in young adult Swedish women.
Introduction
Bone mineral density (BMD) is one of the most important factors contributing to future fracture risk [1] . Bone mass after menopause depends to a great extent on the amount of bone attained during young adulthood and the rate at which bone is subsequently lost. The maximum amount, peak bone mass, plays a crucial role. It has been estimated that one standard deviation (SD) increase in peak bone mass could reduce the risk of fracture by as much as 50 % [2] , since individuals who accrue a high peak bone mass are also likely to maintain a higher BMD throughout their lifetime [3] . Peak bone mass is commonly considered to be reached during the third decade of life [4, 5] , albeit not uniformly at all skeletal sites. Hence, peak is reached earlier in the hip than in the spine, with estimates suggesting just before age 20 in the total hip (TH) and up to the early or midthirties in the lumbar spine [6] .
Peak bone mass is a summation of contributing factors, with genetic influence being central [7] [8] [9] , although many environmental and other factors of varying importance modulate bone gains during childhood and adolescence [10] [11] [12] . Bone mass is commonly referred to as BMD, an areal density measurement, while the actual mineral content (bone mineral content, BMC) refers to the total amount of bone mineral [13] [14] [15] . However, the material properties of bone are not only related to bone mass but to all bone strength components such as size and structural bone geometry, including cortical thickness, porosity, and trabecular bone morphology on one hand, and elasticity, matrix compositions, and the mineral phase on the other.
There is evidence to suggest that the intrauterine environment plays an important role, modifying the genetically determined skeletal potential. Intrauterine growth restriction, other adverse stimulus in fetal life or preterm birth, reflected in low birth weight and also events immediately after birth, can potentially induce permanent effects on the skeleton [16] . It has been proposed that programming of BMC within the periosteal envelope occurs during the intrauterine and early postnatal period [17, 18] . This is later affected by other modulators contributing to BMD, bone strength, and subsequently peak bone mass.
Earlier studies have indicated that birth weight is associated with bone mass, although studied in smaller populations and in various age groups. The influence of birth weight on bone mass at older ages (>60 years) is less clear [19] , while studies in younger individuals indicate that birth weight effects are more pronounced for BMC than BMD [13, 20] .
Recognizing the importance of obtaining high peak bone mass, it is clearly meaningful to evaluate factors determining early skeletal development which have potential longterm effects. Birth weight, as an indicator of prenatal health, might be one such factor, enhancing or reducing the likelihood of reaching the preprogrammed maximum bone mass. Hence, studying individuals during their third decade, when by most definitions they have reached peak bone mass, should be highly informative. While the association between birth weight and bone mass has been investigated at various ages, none of the studies has specifically targeted the peak period in a large size cohort. The PEAK-25 cohort, consisting of more than 1,000 women, all at the age of 25, was designed to be as closely as possible representative of peak bone mass and is subsequently well-suited to add knowledge regarding the influence of birth weight on young adult bone mass and body composition parameters.
Subjects and methods

Subjects
Identified through a computerized administrative registration system, 2,394 Caucasian women living in the city of Malmö, Sweden were invited to participate in this population-based sample study of 25-year-old women. The only exclusion criteria applied were current pregnancy or having been pregnant within the previous 12 months (102 subjects were excluded). In all, 1,064 women attended the baseline investigation; however, an additional three women were later excluded, since they fell outside the predetermined age range (25.00-25.99 years). The final cohort, hence, includes 1,061 Caucasian women, all 25 years old. The total response rate for the study was 49 %.
The investigation included BMD measurements and birth anthropometrics. Information relating to factors influencing bone density (physical activity, smoking, alcohol, dietary calcium intake, and oral contraceptive use) was assessed through a questionnaire. The study was approved by Lund University Ethics Committee and followed the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants.
Bone mass and body composition BMD and body composition were measured by dual X-ray absorptiometry (DXA, Prodigy, GE Lunar Corp., Madison, WI). The same device was used throughout the entire study. BMC expressed in grams (g) and BMD expressed in grams per square centimeter (g/cm 2 ) were measured in: total body (TB), femoral neck (FN), TH, and lumbar spine L1-L4 (LS). In addition, lean mass and fat mass, in kilograms (kg), were measured through the TB scan. The precision of DXA measurements in our hands has previously been determined as 0.90 % in the FN and 0.65 % in the lumbar spine [21] .
Birth data
Birth-related information was obtained from the birth database at the Swedish National Board of Health and Welfare (SNBHW). Of the participating 1,061 subjects, data on birth weight (g) was available for 1,047 and birth length (cm) for 1,034 women. Information on gestational age was not available. Birth weight was categorized according to the World Health Organization (WHO) classification of birth weight: normal (>2,500 g), low (LBW; 1,500-2,499 g), very low (VLBW; 1,000-1,499 g), and extremely low (ELBW; <1,000 g). This classification system does not include high or very high birth weights; we, therefore, created such a category by applying a +2 SD cutoff which corresponds to ≥4,500 g. The participants were also divided into tertiles by birth weight for statistical analysis.
Anthropometry
Standardized equipment was used to assess anthropometric data including weight (kg) and height (cm). BMI was calculated according to the formula weight / height 2 (kg/m 2 ).
Statistical methods
Baseline descriptive data is reported as mean and SD. Exploratory data analysis using the Shapiro-Wilk test was performed for all variables to assess normality of distribution. To test for linear relationships between birth weight and the variables of interest and to determine effect sizes of birth weight on adult BMC, lean and fat mass, Pearson's correlation coefficient and simple linear regression analysis were used. To examine between-group differences, tertiles of birth weight were analyzed using ANOVA/ANCOVA, followed by pairwise comparisons. Analyses were performed with and without adjustment for current body weight. Statistical analysis was performed using SPSS v17.0 software (SPSS Inc., Chicago, IL). The level of significance was set at p<0.05.
Results
Baseline characteristics including anthropometric, bone mineral, and body composition data are shown in Table 1 .
Mean birth weight was 3,392±537 g and length at birth 50± 2.3 cm. Birth weight distribution according to the WHO classification was 95.7 % normal and 3.8 % low, while only 0.5 % fell into the very low category. None of the women weighed less than 1,000 g (extremely low) at birth, while 2.2 % (n023) weighed 4,500 g or more.
Current body weight and height were correlated with birth weight (r00.20; p<0.001; r00.28; p<0.001, respectively). For length at birth, the correlation was stronger for current body height (r00.35; p<0.001) than for body weight (r00.22; p<0.001).
Including physical activity, alcohol, smoking, and dietary calcium intake as covariates in the regression analysis for birth weight vs. TB-BMC did not change the results (r 00.235-0.245; p<0.001). TB-BMC was not significantly different between users and nonusers of estrogencontaining oral contraceptives (ANOVA; p00.22).
Birth weight was correlated with BMC at all measured sites. The strongest correlations were observed for TB-BMC (r00.24; p<0.001), TH-BMC (r00.17; p<0.001), and FN-BMC (r00.16; p<0.001) (Fig. 1 ) and remained significant after adjustment for current body weight. The estimated effect sizes for a 1 kg change in birth weight on BMC parameters are presented in Table 3 and were equivalent to a 0.3-0.5 SD difference. The largest effect size was observed for TB-BMC (151 g, 95 % CI 114-188). Birth weight was not significantly correlated to BMD at any site after adjustment for current body weight ( Table 2) .
Birth weight correlated with the body composition parameters lean and fat mass, with lean mass also remaining significant after adjustment for current body weight (unadjusted r00.29; p<0.001, adjusted r00.21; p<0.001) (Table 2). The estimated effect size for lean mass was 2.5 kg for every kilogram increase in birth weight, an almost 0.5 SD difference (Table 3) . Fat mass correlated negatively with birth weight after adjustment for current body weight (r0−0.21; p<0.001), but showed a weak positive correlation (r 00.10; p 00.002) when unadjusted. This is reflected in the small effect size (<0.2 SD).
To further determine the magnitude of the association between birth weight, adult bone mass, and body composition, the participants were categorized into tertiles of birth weight; low (≤3,180 g), intermediate (3,181-3,620 g), and high (≥3,621 g). The quantitative results are shown in (Table 4 ). In contrast, differences in BMD between birth weight tertiles were less pronounced (low vs. high; FN-BMD (−2.8 %), TH-BMD (−2.1 %)). Additionally, women in the low birth weight tertile had 7.3 % (p<0.001) lower lean mass values than those in the high birth weight tertile. In order to establish whether the observations from this study were driven only by individuals with the lowest birth weights, those in WHO categories low (LBW) and very low (VLBW) birth weight (n045) were excluded from the analysis. With their removal, the mean birth weight increased by~2 %, from 3,392 g to 3,450 g. The results were largely similar, with the correlation between birth weight and BMC remaining but slightly weaker (TB-BMC (r00.14; p<0.001), FN-BMC (r00.08; p00.02), TH-BMC (r00.09; p00.004), and LS-BMC (r00.09; p00.003)). As before, no association was evident for BMD. The correlations between birth weight and lean mass (r00.23; p<0.001) and fat mass (r0−0.22; p<0.001) were also largely unchanged. Separate analysis of the women in the low and very low birth weight categories identified a correlation only with TH-BMC (r00.31; p00.046), although this may be a function of the small sample number.
Discussion
This study illustrates the long-term influence of birth weight on components of bone and body composition in young adult women, particularly BMC and lean mass. Women with low birth weights had lower BMC at all measured sites as adults, while BMD was largely unaffected. Furthermore, low birth weight was also associated with lean and fat mass. The findings were most pronounced for those with the lowest birth weight, whereas the difference between those in the intermediate and high birth weight categories was negligible. Since women at the age of 25 closely represent maximal bone mass, this study indicates that prenatal life may have implications for the attainment of peak bone mass.
Intrauterine growth restriction has implications for a range of conditions [16, 22, 23] and studies have been performed to determine the relationship between birth weight, adult bone mass, and future fracture risk. With peak bone mass as a key stage in skeletal development prior to the onset of the natural process of age-associated bone loss, determination of the relationship between birth weight and bone mass in early adulthood is imperative. Although numerous studies have been performed [18, 19, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] , only a limited number involved women around the third decade and these generally employed small sample sizes. Hence the findings of our study enhances current knowledge and supports the idea of invoking preventive measures, while parental awareness may be warranted for those with or at risk of lower birth weights.
The finding of a clear positive association between birth weight and BMC in TB, FN, TH, and lumbar spine in 25-year-old women is in agreement with the published literature. The absence of an association with bone density after adult body weight is taken into consideration is also in general agreement with the literature [13, 20] and also specifically in women in the peak bone mass age interval [24, 27, 32] . Although the mechanism is not fully clear, a possible explanation for these observations is that the periosteal bone envelope may be determined by the growth trajectory which determines skeletal size, which is most closely related to BMC. Within this envelope, BMD develops, modulated primarily by mechanical loading and other environmental factors [18] .
The clinical relevance of the findings lie in the fact that both BMC and BMD are important determinants of bone strength and even if BMC, compared to BMD, is Body composition variables were adjusted for current body weight a poorer predictor of hip fracture, the findings have important implications, nonetheless, since increased fracture risk secondary to decreased BMC has been described [13-15, 20, 40] . The estimated effect of birth weight on BMC for each 1 kg in birth weight was equivalent to a difference of 0.3-0.5 SD, which could correspond to measurable effects on future osteoporosis risk. In their meta-analysis, Baird et al. inferred that values similar to those we report could be extrapolated into an equivalent relative risk for hip fracture of 1.12 in elderly women [20] . These quantitative changes support the assumption of intrauterine programming for future skeletal development. An interesting finding from this analysis was the observation of a more pronounced association between lower birth weight and BMC than with high birth weight, with the interpretation that lower birth weight has a greater negative influence leading to low BMC than high birth weight has an influence in the opposite direction. A possible biological explanation is that bone size has upper limits in terms of length and width, which, even accounting for differences in prenatal growth or the growth trajectory, cannot be expanded. Thereafter, very high birth weight babies may have other metabolic shortfalls with negative effects on BMC and bone mass. This is supported by the attenuated correlations when those with WHO classified low and very low birth weight were excluded from the analyses. Analyzing these low and very low birth weight individuals separately demonstrated a significant correlation only with TH-BMC; however, the low number of individuals renders a comprehensive subanalysis nonmeaningful. Unfortunately, a clinically relevant cutoff point for birth weight as a risk factor of low bone mass, although interesting, would be difficult to identify.
Both adult lean and fat mass were associated with birth weight. Lean mass was significantly correlated with birth weight even after adjustment for current body weight. Adult lean mass is a predictor of BMC [41, 42] , and in the PEAK-25 cohort, it explained 23-36 % of the variance in BMC (data not shown). Fat mass, on the other hand, showed a weakly positive correlation with birth weight and was inverse after adjustment for current body weight. A possible explanation is that since body weight constitutes lean mass, fat mass, and BMC, individuals with higher body weight have proportionally greater body fat rather than lean mass or BMC, both of which are associated with lower birth weight and made apparent with the adjustment.
A major strength of this study is that the PEAK-25 cohort was designed specifically to evaluate bone mass in women at the time of maximum accrual. The single age group and gender minimizes the confounding contribution of age and sex to bone metabolism which makes comparison of the effect size difficult in meta-analyses [20] . To the best of our knowledge, this is the largest population-based study of close-to-peak bone mass in women and we report on the magnitude of the association between birth weight, bone mass, and body composition parameters lean mass and fat mass. Other strengths include the homogeneity of the individuals, who are all from the same catchment area and the fact that the birth weight data is retrieved from validated national databases. Even though our cohort only consists of Caucasians, it is likely that the results are applicable to other ethnicities, although the effect size may differ. An assumption indirectly backed by fact that the WHO classification Body composition variables were adjusted for current body weight does not include ethnicity. A limitation of the study is the lack of data on gestational age or other information relating to maternal phenotypes which could have provided additional data on heritable body size. Subsequently it is not possible to make distinctions related to causes of a lower birth weight, mainly intrauterine growth retardation or prematurity. Moreover, the number of subjects with low birth weight according to the WHO classification in our cohort was small, and therefore precludes a robust cause-related analysis. Such analysis would be highly interesting, since pathophysiology is assumed to be different and may influence peak bone mass differently.
In summary, this study shows that women with lower birth weight have lower BMC at 25 years of age, independent of adult body weight, and reduced quantities of lean muscle and fat tissue. The major differences occur in subjects within the lowest birth weight bracket, indicating that low birth weight has a more negative association on BMC than high birth weight has a positive association. Hence, this study indicates that birth weight has a positive association with peak bone mass, with sustained skeletal effects, particularly from low BMC and also lean mass, which could, in the long-term, increase the risk of osteoporosis and fracture.
